Literature DB >> 9669295

Immunomodulatory treatment of Graves' ophthalmopathy.

M F Prummel1, W M Wiersinga.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9669295     DOI： 10.1089/thy.1998.8.545

Source DB:  PubMed          Journal:  Thyroid        ISSN： 1050-7256            Impact factor:   6.568


× No keyword cloud information.
  2 in total

1.  De novo triiodothyronine formation from thyrocytes activated by thyroid-stimulating hormone.

Authors:  Cintia E Citterio; Balaji Veluswamy; Sarah J Morgan; Valerie A Galton; J Paul Banga; Stephen Atkins; Yoshiaki Morishita; Susanne Neumann; Rauf Latif; Marvin C Gershengorn; Terry J Smith; Peter Arvan
Journal:  J Biol Chem       Date:  2017-07-25       Impact factor: 5.157

2.  99Tc-MDP treatment for the therapy of rheumatoid arthritis, choroidal neovascularisation and Graves' ophthalmopathy.

Authors:  Qian Wu; Yang Ni; Qingrui Yang; Hongsheng Sun
Journal:  Biomed Rep       Date:  2016-02-23
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.